Fidelity Advisor Biotechnology Fund NUVL Holdings History
Fidelity Advisor Biotechnology Fund's Nuvalent Inc Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 407,981.00 shares of Nuvalent Inc(NUVL), totaling $31.31 Mil. This investment constitutes 2.31% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.57% of the outstanding Nuvalent Inc(NUVL) stock.
The initial trade took place in 2021Q4. And since then Fidelity Advisor Biotechnology Fund has made 11 purchases of NUVL, at an average price of $22.98, for a total of 888,906.00 shares. In addition, there have been 3 sales at an average price of $47.42 for 480,925.00 shares. Based on historical transaction data and NUVL's current price of $83.40, Fidelity Advisor Biotechnology Fund's estimated gain on his NUVL holdings is $36.40 Mil, reflecting a 178.22% gain to date.
Fidelity Advisor Biotechnology Fund NUVL ($83.40) Holding Chart
Fidelity Advisor Biotechnology Fund NUVL ($83.40) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
